Novel adenosine 5′-triphosphate-sensitive potassium channel ligands: a patent overview (2005 – 2010)

Bibliography

• Seino S, Mikit T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 2003;81:133-76
   PubMed Web of Science ®Google Scholar
• Jahangir A, Terzic A. KATP channel therapeutics at the bedside J Mol Cell Cardiol 2005;39(1):99-112
   PubMed Web of Science ®Google Scholar
• Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999;61:337-62
   PubMed Web of Science ®Google Scholar
• Bond CT, Ammala C, Ashfield R, Cloning and functional expression of the cDNA encoding an inwardly-rectifying potassium channel expressed in pancreatic beta-cells and in the brain. FEBS Letter 1995;367(1):61-6
   PubMed Web of Science ®Google Scholar
• Clement JP, Kunjilwar K, Gonzalez G, Association and stoichiometry of K(ATP) channel subunits. Neuron 1997;18(5):827-38
   PubMed Web of Science ®Google Scholar
• Babenko AP, Aguilar-Bryan L, Bryan J. A view of Sur/Kir6.x, KATP channels. Annu Rev Physiol 1998;60:667-87
   PubMed Web of Science ®Google Scholar
• Inagaki N, Gonoi T, Clement JP, A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 1996;16(5):1011-7
   PubMed Web of Science ®Google Scholar
• Isomoto S, Kondo C, Yamada M, A novel sulphonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K+ channel. J Biol Chem 1996;271(40):24321-4
   PubMed Web of Science ®Google Scholar
• Zhang HL, Bolton TB. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol 1996;118:105-14
   PubMed Web of Science ®Google Scholar
• Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991;352:244-47
   PubMed Web of Science ®Google Scholar
• Paucek P, Mironova G, Mahdi E, Reconstruction and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J Biol Chem 1992;267:26062-69
   PubMed Web of Science ®Google Scholar
• Bajgar R, Seetharaman S, Kowaltowski AJ, Identyfication and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001;276:33369-74
   PubMed Web of Science ®Google Scholar
• Cancherini DV, Trabuco LG, Reboucas NA, Kowaltowski AJ. ATP-sensitive K+ channels in renal mitochondria. Am J Physiol Renal Physiol 2003;285:F1291-6
   Web of Science ®Google Scholar
• Debska G, Kicinska A, Skalska J, Opening of potassium channels modulates mitochondrial function in rat skeletal muscle. Biochim Biophys Acta 2002;1556:97-105
   PubMed Web of Science ®Google Scholar
• Halestrap AP. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 1989;973:355-82
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 1984;312:446-8
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic b-cell. Prog Biophys Mol Biol 1989;54:87-143
   PubMed Web of Science ®Google Scholar
• Gopel SO. Regulation of glucagons release in mouse-cells by KATP channels and inactivation of TTX-sensitive Na+ Channels. J Physiol 2000;528:509-20
   PubMed Web of Science ®Google Scholar
• Gopel SO, Kanno T, Barg S, Rorsman P. Patch-clamp characterization of somatostatin-secreting – cells in intact mouse pancreatic islets. J Physiol 2000;528:497-507
   PubMed Web of Science ®Google Scholar
• Nichols CG, Koster JC, Remedi MS. beta-cell hyperexcitability: from hyperinsulinism to diabetes. Diabetes Obes Metab 2007;9(Suppl 2):81-8
   PubMedGoogle Scholar
• Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005;115:2047-58
   PubMed Web of Science ®Google Scholar
• Dunne MJ, Cosgrove KE, Shepherd RM, Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 2004;84(1):239-75
   PubMed Web of Science ®Google Scholar
• Abraham MR, Jahangir A, Alekseev AE, Terzic A. Channelopathies of inwardly rectifying potassium channels. FASEB J 1999;13(14):1901-10
   PubMed Web of Science ®Google Scholar
• De Tullio P, Lebrun P, Florence X, Selective pancreatic ATP-sensitive-potassium channel openers for the treatment of glucose homeostasis disorder. Drugs Fut 2006;31:991-1001
   Web of Science ®Google Scholar
• Teramoto N. Physiological roles of ATP-sensitive K+ channels in smooth muscle. J Physiol 2006;572(Pt 3):617-24
   PubMed Web of Science ®Google Scholar
• Curley M, Cairns MT, Friel AM, Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. Mol Hum Reprod 2002;8:941-5
   PubMed Web of Science ®Google Scholar
• Insuk SO, Chae MR, Choi JW, Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells. Int J Impot Res 2003;15(4):258-66
   PubMed Web of Science ®Google Scholar
• Haynes JM, Cook AL. Protein kinase G-induced activation of K(ATP) channels reduces contractility of human prostate tissue. Prostate 2006;66:377-85
   PubMed Web of Science ®Google Scholar
• Davies NW. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons. Nature 1990;343(6256):375-7
   PubMed Web of Science ®Google Scholar
• El-Hashim AZ, Buchheit KH, Fozard J, Page C. Effect of the K+(ATP) channel opener, KCO912, on baseline and allergen induced airway hyperresponsiveness in allergic rabbits. Eur J Pharmacol 2004;484(2-3):351-6
   PubMed Web of Science ®Google Scholar
• Pelaia G, Gallelli L, Vatrella A, Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci 2002;70(9):977-90
   PubMed Web of Science ®Google Scholar
• Ramnarine SI, Liu YC, Rogers DF. Neuroregulation of mucus secretion by opioid receptors and K(ATP) and BK(Ca) channels in ferret trachea in vitro. Br J Pharmacol 1998;123(8):1631-8
   PubMed Web of Science ®Google Scholar
• Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-86
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan M, Shieh CC, Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders. Exp Opin Ther Targets 2004;8:437-58
   PubMed Web of Science ®Google Scholar
• Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983;305:147-8
   PubMed Web of Science ®Google Scholar
• Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000;32:677-95
   PubMed Web of Science ®Google Scholar
• Kane GC, Liu XK, Yamada S, Cardiac KATP channels in health and disease. J Mol Cell Cardiol 2005;38(6):937-43
   PubMed Web of Science ®Google Scholar
• Kubo M, Quayle JM, Standen NB. Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C. J Physiol 1997;503(Pt 3):489-96
   PubMed Web of Science ®Google Scholar
• Bienengraeber M, Olson TM, Selivanov VA, ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004;36(4):382-7
   PubMed Web of Science ®Google Scholar
• Gok S, Vural K, Sekuri C, Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischaemia-reperfusion model in isolated rat hearts. Vascul Pharmacol 2006;44(4):197-205
   PubMed Web of Science ®Google Scholar
• Facundo HT, Fornazari M, Kowaltowski AJ. Tissue protection mediated by mitochondrial K+ channels. Biochim Biophys Acta 2006;1762:202-12
   PubMed Web of Science ®Google Scholar
• Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischaemia-reperfusion injury. Physiol Rev 2008;88:581-609
   PubMed Web of Science ®Google Scholar
• Cole W, McPherson C, Sontag D. ATP-regulated K+ channels protect the myocardium against ischaemia/reperfusion damage. Circ Res 1991;69:571-81
   PubMed Web of Science ®Google Scholar
• Knopp A, Thierfelder S, Doepner B, Benndorf K. Mitochondria are the main ATP source for a cytosolic pool controlling the activity of ATP-sensitive K(+) channels in mouse cardiac myocytes. Cardiovasc Res 2001;52(2):236-45
   PubMed Web of Science ®Google Scholar
• Sato T, Sasaki N, O'Rourke B, Marban E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 2000;35(2):514-8
   PubMed Web of Science ®Google Scholar
• Yao Z, Gross GJ. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89(4):1769-75
   PubMed Web of Science ®Google Scholar
• Grover GJ, McCullough JR, D'Alonzo AJ, Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J Cardiovasc Pharmacol 1995;25(1):40-50
   PubMed Web of Science ®Google Scholar
• Kulawiak B, Kudin AP, Szewczyk A, Kunz WS. BK channel openers inhibit ROS production of isolated rat brain mitochondria. Exp Neurol 2008;212:543-7
   PubMed Web of Science ®Google Scholar
• Czyz A, Szewczyk A, Nałecz MJ, Wojtczak L. The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria, Biochem Biophys Res Commun 1995;210:98-104
   PubMed Web of Science ®Google Scholar
• Testai L, Rapposelli S, Calderone V. Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy. Cardiovasc Hematol Agents Med Chem 2007;5(1):79-90
   PubMedGoogle Scholar
• Ardehali H, Chen Z, Ko Y, Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity, Proc Natl Acad Sci USA 2004;101:11880-5
   PubMed Web of Science ®Google Scholar
• O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res 2004;94:420-32
   PubMed Web of Science ®Google Scholar
• Busija DW, Lacza Z, Rajapakse N, Targeting mitochondrial ATP-sensitive potassium channels—a novel approach to neuroprotection. Brain Res Brain Res Rev 2004;46:282-94
   PubMedGoogle Scholar
• O'Rourke B. Myocardial KATP channels in preconditioning, Circ Res 2000;87:845-55
   PubMed Web of Science ®Google Scholar
• Bajgar R, Seetharaman S, Kowaltowski AJ, Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001;276(36):33369-74
   PubMed Web of Science ®Google Scholar
• Kis B, Nagy K, Snipes JA, The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport 2004;15(2):345-9
   PubMed Web of Science ®Google Scholar
• Chi X, Sutton ET, Hellermann G, Price JM. Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells. Neurosci Lett 2000;290:9-12
   PubMed Web of Science ®Google Scholar
• Correia SC, Santos RX, Perry G, Mitochondria: The missing link between preconditioning and neuroprotection. J Alz Disease 2010; 20(Suppl 2):475-85
   Google Scholar
• Zhang S, Ding JH, Zhou F, Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels. J Neurosci Res 2009;87(5):1230-9
   PubMed Web of Science ®Google Scholar
• Mazarati A. ATP-dependent potassium channels: a converging target for endogenous anticonvulsant factors. Epilepsy Curr 2005;5(4):139-41
   PubMedGoogle Scholar
• Lohmann AB, Welch SP. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides. Eur J Pharmacol 1999;385:119-27
   PubMed Web of Science ®Google Scholar
• Ocana M, Cendán CM, Cobos EJ, Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol 2004;500:203-19
   PubMed Web of Science ®Google Scholar
• Alekseev AE, Reyes S, Yamada S, Sarcolemmal ATP-sensitive K+ channels control. Energy expenditure determining body weight. Cell Metab 2010;11:58-69
   PubMed Web of Science ®Google Scholar
• Cardoso AR, Cabral-Costa JV, Kowaltowski AJ. Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation. J Bioenerg Biomembr 2010;42:245-53
   PubMed Web of Science ®Google Scholar
• Mannhold R. Structure-activity relationships of K(ATP) channel openers. Curr Top Med Chem 2006;6(10):1031-47
   PubMed Web of Science ®Google Scholar
• Wang H, Tang Y, Wang L, ATP-sensitive potassium channel openers and 2,3-dimethyl-2-butylamine derivatives. Curr Med Chem 2007;14(2):133-65
   PubMed Web of Science ®Google Scholar
• Lawson K. Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int 2000;57:838-45
   PubMed Web of Science ®Google Scholar
• Solvay Pharmaceuticals GMBH. Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators. WO2007125048; 2007
   Google Scholar
• Solvay Pharmaceuticals GMBH. Use of CBX cannabinoid receptor modulators as potassium channel modulators. WO2007125049; 2007
   Google Scholar
• Cota D, Marsicano G, Tschop M, The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112(3):423-31
   PubMed Web of Science ®Google Scholar
• Hansen JB. Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. Curr Med Chem 2006;13(4):361-76
   PubMed Web of Science ®Google Scholar
• Coöperatieve Mirzorg U.A. Use of a combination of diazoxide and metformin for treating obesity or obesity related compounds. WO2010093243, 2010
   Google Scholar
• Universita di Pisa. Pharmacodynamic hybrids endowed of hypoglicaemic and NO-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids. WO2008017925, 2008
   Google Scholar
• Calderone V, Rapposelli S, Martelli A, NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs. Bioorg Med Chem 2009;17:5426-32
   PubMed Web of Science ®Google Scholar
• Auspex Pharmaceuticals, Inc. Sulfonylurea inhibitors of ATP-sensitive potassium channels. US20100056546; 2010
   Google Scholar
• Auspex Pharmaceuticals, Inc. Sulfonylurea inhibitors of ATP-sensitive potassium channels. US20100130615; 2010
   Google Scholar
• Auspex Pharmaceuticals, Inc. Benzoic acid inhibitors of ATP-sensitive potassium channels. US20100120861; 2010
   Google Scholar
• Auspex Pharmaceuticals, Inc. Phenylalanine amide inhibitors of ATP-sensitive potassium channels. WO2010060041; 2010
   Google Scholar
• Essentialis Inc. Salts of potassium ATP channel openers and uses thereof. US20100028429; 2010
   Google Scholar
• Essentialis Inc. Pharmaceutical formulations of potassium ATP channel openers and use thereof. US20090149451; 2009
   Google Scholar
• Albert Einstein College of Medicine of Yeshiva University, Signum Pharmaceutical Inc. Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels. WO2006088875; 2006
   Google Scholar
• Herlands L, Pocai A, Rossetti L. Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels. US20070026079; 2007
   Google Scholar
• Albert Einstein College of Medicine of Yeshiva University. Modulation of hypothalamic ATP-sensitive potassium channels. US20090012067; 2009
   Google Scholar
• Università di Pisa. Nitrogenous N-substituted 4-spiro-heterocyclic 2,2-dimethylchromane derivatives. WO2008007210; 2008
   Google Scholar
• Calderone V, Testai L, Martelli A, Anti-ischaemic properties of a new spiro-cyclic benzopyran activator of the cardiac mitoKATP channel. Biochem Pharmacol 2010;79:39-47
   PubMed Web of Science ®Google Scholar
• Rapposelli S, Calderone V, Cirilli R, Enantioselectivity in Cardioprotection induced by (S)-(−)-2,2-Dimethyl-N-(4′-acetamido-benzyl)-4-spiromorpholone-chromane. J Med Chem 2009;52(5):1477-80
   PubMed Web of Science ®Google Scholar
• Breschi MC, Calderone V, Digiacomo M, Spirocyclic Benzopyran-based derivatives as new anti-ischaemic activators of mitochondrial ATP-sensitive potassium channel. J Med Chem 2008;51(21):6945-54
   PubMed Web of Science ®Google Scholar
• Hybernation Therapeutics Ltd. Organ protection, preservation and recovery. US20100256083; 2010
   Google Scholar
• University of Rochester. Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage. WO2007053514; 2007
   Google Scholar
• Zhang X, Qiu Y, Li X, Discovery and structure–activity relationships of a novel series of benzopyran-based KATP openers for urge urinary incontinence. Bioorg Med Chem 2009;17:855-66
   PubMed Web of Science ®Google Scholar
• Zhang X, Sui Z. Novel tricyclic dihydropyrazines as potassium channel openers. US20070191382; 2007
   Google Scholar
• Janssen Pharmaceutica NV. Novel tricyclic dihydropyrazines as potassium channel openers. WO2007095424; 2007
   Google Scholar
• Janssen Pharmaceutica NV. Novel pyridine derivatives as potassium ion channel openers. WO2006091800; 2006
   Google Scholar
• Janssen Pharmaceutica NV. Novel coumarin derivatives as ion channel openers. WO2006078833; 2006
   Google Scholar
• Janssen Pharmaceutica NV. Novel benzopyran derivatives as potassium channel openers. WO2007027780; 2007
   Google Scholar
• Janssen Pharmaceutica NV. Novel quinoline derivatives as potassium ion channel openers. WO2006091769; 2006
   Google Scholar
• Lanter JC, Sui Z. 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers. US20090312412; 2009
   Google Scholar
• Zhang X, Sui Z. Novel pyrazolylquinazolinones as potassium channel openers. US20070197566; 2007
   Google Scholar
• Shenyang Pharmaceutical University. Application of chromane HEF-05 in relaxation of vascular smooth muscles. CN101829081; 2010
   Google Scholar
• Shenyang Pharmaceutical University. New medical application of chromane compound HEF-05. CN101618033; 2010
   Google Scholar
• Region Hovedstaden Glostrup Hospital, Olesen IJ, Olesen J. Treatment of migraine and headaches. WO2007009462; 2007
   Google Scholar